Consistent with the TCGA data, western blot analysis demonstrated markedly higher CDKN2A protein levels in tumour tissues compared to their normal counterparts (Figure 4C), confirming the clinical relevance of CDKN2A overexpression in CRC. This evidence concerns the gene CDKN2A and colorectal carcinoma.